Navigation Links
FDA Accepts ISO-Vorin(TM) New Drug Application Amendment Submitted by Spectrum Pharmaceuticals
Date:9/13/2007

- FDA Targets January 11, 2008 as Action Date

IRVINE, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc., (Nasdaq: SPPI) today announced that the amendment to the New Drug Application (NDA) for ISO-Vorin(TM) (levofolinic acid, or LFA) for injection has been accepted by the U.S. Food & Drug Administration (FDA). The FDA has targeted January 11, 2008 as its action date regarding the approval of the ISO-Vorin(TM) application. ISO-Vorin(TM) is the pure active isomer of calcium leucovorin. Calcium leucovorin is used after the administration of high-dose methotrexate in treating osteogenic sarcoma and is also a component of "standard of care" 5-fluorouracil (5-FU) containing regimens for the treatment of colorectal and other malignancies.

"The acceptance by the FDA of the ISO-Vorin(TM) NDA amendment represents an important milestone for Spectrum as it provides validation of our risk-reduced business model," said Rajesh C. Shrotriya, M.D., Chairman, President and Chief Executive Officer of Spectrum Pharmaceuticals. "ISO-Vorin(TM) represents one of eleven promising drugs in our pipeline that have the potential to be effective therapeutic agents."

The FDA's Oncology Drug Advisory Committee had already recommended ISO-Vorin(TM) for approval, based upon clinical data demonstrating the efficacy, safety and bioequivalency in comparison to the racemic leucovorin form. During a review of the NDA application, the FDA raised questions surrounding the chemistry manufacturing and control section of the NDA. The amendment to the NDA provided manufacturing information and six months stability data on commercial batches, required by the FDA to complete its review of the ISO-Vorin(TM) NDA
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. UWM accepts resignation of research dean
2. A Versatile Power Supply for All Electrophoresis Applications
3. Highest Possible Transformation Efficiencies for High-Throughput Applications
4. Unique DNA Polymerase Formulation Excels in a Broad Range of PCR Applications
5. High-Throughput System Generates Ultra-Pure PCR Products Suitable for All Applications
6. An Assessment of the Eppendorf twin.tec plate performance in PCR* applications
7. Principles and applications of electrical cell fusion
8. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
9. Optimizing Büchi® Rotary Evaporator Applications
10. Principles and applications of electrical cell fusion
11. Eppendorf Electroporation Application Notes Your participation is highly welcome !!!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 With the accelerated aging ... health expenditure as well as the improved medical ... diagnostic reagent industry has been developing quickly, especially ... 2013, Chinese in vitro diagnostics market size reached ... in vitro diagnostic reagents. , Read complete ...
(Date:7/30/2014)... SAN DIEGO , July 30, 2014  Orexigen ... it has received the Day 180 List of Outstanding ... Medicinal Products for Human Use (CHMP) for the NB32 ... / bupropion SR) is an investigational drug candidate being ... of the earlier Day 120 time point were adequately ...
(Date:7/30/2014)... , July 30, 2014  RXi ... a biotechnology company focused on discovering, developing ... medical needs using RNA-targeted technologies, today announced ... with RXI-109, for the reduction of recurrence ... surgery, has been initiated. Logo ...
(Date:7/30/2014)... July 30, 2014 Immunology ... leading Immunologists, Principle Investigators, scientists in the field, ... Malemud, Professor at Case Western Reserve University School ... keynote address on “The effects of recombinant ... of matrix metalloproteinase-9”. Arya Biragyn, a Senior investigator ...
Breaking Biology Technology:China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5Unveiling Breakthroughs in Clinical & Cellular Immunology 2Unveiling Breakthroughs in Clinical & Cellular Immunology 3
... Oct. 1 Maven Biotechnologies today announced that the ... Institute for Allergy and Infectious Disease (NIAID), part of ... TM imaging technology for label-free protein microarrays and ... Maven through the federal stimulus package initiative for Biomedical ...
... The Culex quinquefasciatus mosquito poses a significant ... elephantiasis-causing worms and encephalitis-inducing viruses. An international team of ... the SIB Swiss Institute of Bioinformatics sequenced its genome ... published in today,s issue of Science, describe results from ...
... 1 Vet-Stem, Inc. announced that Dr. Robert Harman, ... entitled "Stem Cell Therapy: Mechanisms of Action" at the ... Surgeons (ACVS) in Seattle, WA, October 21, 2010.   ... http://www.newscom.com/cgi-bin/prnh/20060425/VETSTEMLOGO ) Dr. Harman has presented ...
Cached Biology Technology:Maven Biotechnologies Receives $1.96 Million From the National Institutes of Health (NIH) to Develop Their LFIRE™ Label-Free Detection Technology for Proteomics 2Major disease-vector mosquito reveals the secrets of its immune system 2Vet-Stem CEO to Present Invited Talk at Veterinary Surgery Meeting 2
(Date:7/30/2014)... Sciences Institute (SALSI), a joint venture between The University ... of Texas Health Science Center at San Antonio, has ... The winners, Emily Boice from UTSA and Lei Huang ... their project titled, "Novel engineered ferritins for tracking and ... and Huang,s research is focused on finding a treatment ...
(Date:7/30/2014)... associate professor Andrew S. Mount, performed cutting-edge research on ... novel anti-fouling paint for ships and boats and also ... team,s findings, published in Nature Communications ... attaches to a wide variety of surfaces using highly ... underwater heavy-duty adhesive. , "In previous research, we were ...
(Date:7/30/2014)... pests, shrinking ranges and a changing climate threaten ... important plants, and so conservationists establish seed collections ... gardens in hopes of preserving some genetic diversity., ... by simple models that offer a one-size-fits-all approach ... recommending saving 50 seed samples regardless of species, ...
Breaking Biology News(10 mins):Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Saving seeds the right way can save the world's plants 2
... researchers are part of a nationwide team preparing to open ... genome of the single living sister species to all other ... a large shrub found only on the South Pacific island ... diversified over time and provide insight into the key processes ...
... The Ohio State University and Ohio Supercomputer Center ... develop a computer tool that researchers, government leaders and ... in energy-related technology, policy and pricing. Researchers will ... for Energy Pricing and Policy (ICS-EPP), which models the ...
... PHILADELPHIA The American Association for Cancer Research congratulates 12 ... Medicine. They are among the 65 new members and five ... the fields of health and medicine, the award recognizes individuals ... in the fields of health and medicine. "This ...
Cached Biology News:UF to help sequence genome of flowering plants' ancient living relative 2UF to help sequence genome of flowering plants' ancient living relative 3NSF grant to study national energy policy and technology impacts 2The AACR congratulates its members elected to the Institute of Medicine 2
... is designed to knockout or alter genes on ... one week. Red/ET recombination allows the exchange of ... and faithful manner. An FRT-flanked kanamycin resistance marker ... be used to replace a gene on the ...
Recommended for use as a cell culture substratum at 0.1-0.2 mg/cm 2 or 5-10 μl/cm 2 . Optimal concentration depends on cell type as well as the application or research objectives. Type B...
... Yellow crystalline solid. PROTECT FROM LIGHT. Useful in cell ... Purity: ≥98% by TLC. Soluble in DMSO ... of a 10 mM stock in DMSO is recommended. ... H 2 O with rapid mixing (e.g. 10 μl ...
... to Protein A and, until recently, no readily ... IgM purification. Standard methods for IgM purification generally ... effective for removing all of the major impurities ... Pierce has developed an easy-to-use affinity matrix ...
Biology Products: